Header cover image

South African (JSE) Pharma Industry Analysis

UpdatedApr 25, 2024
DataAggregated Company Financials
Companies3
  • 7D-3.0%
  • 3M10.5%
  • 1Y18.0%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 1.2%, driven by a pullback from Aspen Pharmacare Holdings of 1.3%. Over the past 12 months, the industry was up 17%. Looking forward, earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the South African Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Apr 2024R105.1bR53.4bR5.7b14.7x18.5x2x
Sat, 23 Mar 2024R104.6bR53.4bR5.5b14.6x19.2x2x
Mon, 19 Feb 2024R97.4bR51.4bR5.8b13.1x16.7x1.9x
Wed, 17 Jan 2024R99.1bR51.4bR5.8b13.5x17x1.9x
Fri, 15 Dec 2023R97.1bR51.4bR5.8b13.4x16.6x1.9x
Sun, 12 Nov 2023R84.9bR51.4bR5.8b11.9x14.5x1.7x
Tue, 10 Oct 2023R84.6bR51.4bR5.8b12x14.5x1.6x
Thu, 07 Sep 2023R81.5bR51.4bR5.9b11.5x13.9x1.6x
Sat, 05 Aug 2023R94.4bR49.0bR6.4b12.1x14.7x1.9x
Mon, 03 Jul 2023R90.7bR49.0bR6.4b11.9x14.1x1.9x
Wed, 31 May 2023R84.9bR49.0bR6.4b11.2x13.2x1.7x
Fri, 28 Apr 2023R89.5bR49.0bR6.4b11.6x14x1.8x
Sun, 26 Mar 2023R89.1bR49.0bR5.9b11.7x15.1x1.8x
Tue, 21 Feb 2023R74.7bR48.9bR6.5b10.3x11.4x1.5x
Thu, 19 Jan 2023R74.1bR48.9bR6.5b10.1x11.4x1.5x
Sat, 17 Dec 2022R69.0bR48.9bR6.5b9.8x10.6x1.4x
Mon, 14 Nov 2022R75.6bR48.9bR6.5b10.1x11.6x1.5x
Wed, 12 Oct 2022R70.9bR48.9bR6.5b9.7x10.9x1.5x
Fri, 09 Sep 2022R74.5bR49.3bR5.8b10x12.8x1.5x
Sun, 07 Aug 2022R73.8bR48.9bR5.2b10.9x14.3x1.5x
Tue, 05 Jul 2022R70.0bR48.9bR5.2b10.5x13.6x1.4x
Thu, 02 Jun 2022R78.3bR48.9bR5.2b11.4x15.2x1.6x
Sat, 30 Apr 2022R85.8bR48.9bR5.2b12.2x16.6x1.8x
Mon, 28 Mar 2022R97.4bR48.3bR5.1b14x19.2x2x
Wed, 23 Feb 2022R101.6bR47.6bR4.0b15.8x25.4x2.1x
Fri, 21 Jan 2022R105.2bR45.5bR5.5b16.4x19.3x2.3x
Sun, 19 Dec 2021R110.4bR45.5bR5.5b16.7x20.2x2.4x
Tue, 16 Nov 2021R106.6bR45.5bR5.5b16.2x19.5x2.3x
Thu, 14 Oct 2021R118.5bR45.5bR5.5b17.3x21.7x2.6x
Sat, 11 Sep 2021R107.2bR53.5bR4.2b16x25.2x2x
Mon, 09 Aug 2021R89.1bR53.5bR4.2b14x21x1.7x
Sun, 02 May 2021R80.8bR56.3bR4.6b12.6x17.5x1.4x
Price to Earnings Ratio

17.5x


Total Market Cap: R80.8bTotal Earnings: R4.6bTotal Revenue: R56.3bTotal Market Cap vs Earnings and Revenue0%0%0%
South African Pharma Industry Price to Earnings3Y Average 16.3x202220232024
Current Industry PE
    There are only 3 companies in the South African Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 7.3% per year over the last three years, while revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Comparison

How does South African Pharma compare with similar industries?

ZA Market1.09%
Healthcare-1.98%
Pharma-3.01%
Pharma-3.01%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AIP Adcock Ingram HoldingsR55.502.3%
+R185.8m
10.4%PE9.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ASC

R0.78

Ascendis Health

7D

-2.5%

1Y

25.8%

APN

R216.31

Aspen Pharmacare Holdings

7D

-3.5%

1Y

18.7%

AIP

R55.50

Adcock Ingram Holdings

7D

2.3%

1Y

10.4%